ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,094Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 2604

$712K Total Retail Price of All Prescriptions

Rank: 74 out of 2604

666 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 666 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 666 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,656 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 536 498 1 2
OMEPRAZOLE 447 412 2 5
LEVOTHYROXINE SODIUM 329 281 3 4
METOPROLOL SUCCINATE 287 258 4 17
LISINOPRIL 213 187 5 3
HYDROCODONE-ACETAMINOPHEN 210 141 S3 6 1
TAMSULOSIN HCL 208 187 7 30
LOSARTAN POTASSIUM 199 170 8 20
AMLODIPINE BESYLATE 189 173 9 6
METOPROLOL TARTRATE 186 180 10 9
FUROSEMIDE 181 168 11 8
RANITIDINE HCL 177 159 12 25
ZOLPIDEM TARTRATE 159 115 13 21
SERTRALINE HCL 155 137 14 23
POTASSIUM CHLORIDE 136 136 15 16
ATORVASTATIN CALCIUM 127 113 16 19
PANTOPRAZOLE SODIUM 124 123 17 64
ATENOLOL 124 121 17 11
MELOXICAM 123 110 19 36
WARFARIN SODIUM 122 122 20 13
ALLOPURINOL 121 116 21 35
GLIMEPIRIDE 115 109 22 57
TRIAMTERENE-HCTZ 113 96 23 55
CARVEDILOL 112 108 24 26
METFORMIN HCL 111 65 25 7
CITALOPRAM HBR 110 65 26 18
DONEPEZIL HCL 106 106 27 28
LOSARTAN-HYDROCHLOROTHIAZIDE 103 95 28 77
GABAPENTIN 100 73 29 12
CLOPIDOGREL 89 82 30 39
FINASTERIDE 85 83 31 103
ZETIA 85 81 31 94
SYNTHROID 84 84 33 127
AZITHROMYCIN 84 75 33 33
TRAMADOL HCL 83 52 35 15
CIPROFLOXACIN HCL 82 75 36 59
FLUTICASONE PROPIONATE 81 61 37 31
ALPRAZOLAM 79 79 38 119
CRESTOR 78 64 39 47
PLAVIX 76 71 40 75
GLYBURIDE-METFORMIN HCL 74 65 R 41 180
FENOFIBRATE 66 61 42 69
SPIRIVA 66 59 42 45
PREDNISONE 62 53 44 34
SINGULAIR 61 52 45 120
TOPROL XL 59 59 46 461
BUMETANIDE 58 50 47 70
NAMENDA 58 58 47 37
CEFUROXIME 56 46 49 221
ETODOLAC 54 51 50 178
CEPHALEXIN 53 45 51 74
AGGRENOX 53 53 51 206
ACETAMINOPHEN-CODEINE 51 44 S3 53 60
VESICARE 51 51 53 187
PRAVASTATIN SODIUM 50 49 55 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.